Search Results 1161-1170 of 17023 for hla genotype
Mayo Clinic doctors and researchers are studying lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is conducted ...
We will compare the results from the Liat group A streptococcus (Strep A) test to the results of a paired sample run in the laboratory on the LightCycler PCR ...
Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from ...
The purpose of this study is to compare myocardial stiffness between subjects with and without heart failure with preserved ejection fraction (HFpEF).
If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...
About this study. This is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered as a ...
The purpose of this study is to test for a clinical and genetic association between Myotonic Dystrophy Type 1 (DM1) and Fuchs endothelial corneal dystrophy ( ...
Under Dr. Roberts, the Hepatobiliary Cancer Lab at Mayo Clinic collaborates with other institutions on hepatobiliary cancer research and patient registries.
Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!